# Giant Extracranial Meningioma Associated With Hormonal Imbalances Due to Thyroidectomy: Case Report and Literature Review

## TL;DR

A 67-year-old woman with a large malignant meningioma and hormonal issues after thyroidectomy is reported, highlighting the need for multidisciplinary care in such complex cases.

## Contribution

This case report adds to the literature on giant malignant meningiomas and explores the potential role of endocrine dysfunction in tumor progression.

## Key findings

- The patient had a giant, malignant meningioma following thyroidectomy and endocrine dysfunction.
- Postoperative complications led to the patient's death, emphasizing the challenges in managing such tumors.
- The report highlights the need for further research on endocrine factors in meningioma pathogenesis.

## Abstract

Meningiomas represent a prevalent class of primary brain tumors, with malignancies such as World Health Organization grade III meningiomas posing significant clinical challenges due to their aggressive nature and potential for recurrence. This case report showcases the clinical journey of a 67-year-old female patient presenting with a giant malignant meningioma post-thyroidectomy, who unfortunately succumbed to postoperative complications. The report offers a comprehensive analysis of the tumor's clinical presentation, including its substantial size, which qualifies it as a 'giant' meningioma, and explores the patient's endocrine dysfunction as a possible contributing factor to her neurological pathology. In the broader context of meningioma management, the report synthesizes data from multiple studies, underscoring the higher incidence of such malignancies in post-pubertal women and the complexity of treatment modalities. Surgical resection remains the cornerstone of treatment, especially when combined with adjuvant therapies. The report concludes with a discussion on the persistent gaps in knowledge regarding the pathogenesis of giant malignant meningiomas and the need for further research, particularly concerning the role of endocrine dysregulation in their development. This case underscores the imperative for multidisciplinary approaches and individualized treatment strategies in the management of malignant meningiomas, with an emphasis on the intricate interplay between endocrine factors and tumor progression.